Л. В. Мороз
National Pirogov Memorial Medical University, Vinnytsya · 72 works · 712 citations · h-index 8
Top works
- Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
- 1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL
- HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey
- A situational picture of HIV/AIDS and injection drug use in Vinnitsya, Ukraine
- Resistance to Doxorubicin in Tumor Cells in vitro and in vivo after Pretreatment with Verapamil
- Colloidal Silicon Dioxide in Tablet form (Carbowhite) Efficacy in Patients with Acute Diarrhea: Results of Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
- IFN-λ-3 (IL28B) genotyping by restriction fragment length polymorphism method: detection polymorphism of rs12979860
- Genotype Distribution and Characteristics of Chronic Hepatitis C Infection in Estonia, Latvia, Lithuania, and Ukraine: The RESPOND-C Study
- MODERN APPROACHES IN MANAGEMENT OF CHILDREN WITH CHRONIC HEPATITIS B IN REMISSION OF ACUTE LYMPHOBLASTIC LEUKEMIA.
- Peculiarities of Immune Status among Young Patients with Community-Acquired Pneumonia (CAP) during Cytomegaloviral Persistence (CMVP)
- Use of glutathione inhibitors and glutathione transferases to overcome tumor resistance to cytostaticsin vivo
- Quercetin effectiveness in patients with COVID-19 associated pneumonia
- Investigation of rs11536889 + 3725G/C Polymorphism of the TLR4 Gene in Patients with Autoimmune and Chronic Viral Hepatitis C
- [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma].
- Controlled release recombinant human interferon‐α2b for treating patients with chronic hepatitis C genotype 1: a phase 2a clinical trial
- Клинический случай тяжелого течения микст-малярии (Рl. falciparum, Рl. malariae) у пациента украинского происхождения
- VITAMIN D AS ONE OF PREDICATORS OF THE STABLE VIRAL RESPONSE TO ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIS HEPATITIS С
- IFNL4 polymorphism as a predictor of chronic hepatitis C treatment efficiency in Ukrainian patients
- Congenital hepatic fibrosis (a case report)
- 848 VIRAL KINETICS DURING TREATMENT WITH A CONTROLLED-RELEASE RECOMBINANT INTERFERON ALFA 2B IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS